Phonophobia
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention (NCT05207865) | Pfizer | 2022-03-15 |
| An Efficacy Study of a Single Dose Treatment of PRO-513 for Subjects Suffering a Migraine Attack (NCT00330850) | ProEthic Pharmaceuticals | 2006-05-01 |
Track Phonophobia automatically
Every clearance here is in the API, with alerts when new ones post.